← Leaderboards
Steven Gitelman
University Of California San Francisco
$25,799
Attributed
$25,799
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$25,799 · 2
By mechanism
M01$25,799 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Matthias Hebrok$19,978,612
- Michael S German$33,618,125
- Feroz R Papa$19,804,607
- Douglas Hanahan$19,892,030
- Stephen E Gitelman$12,344,642
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAutoimmunityDiabetes Mellitus TherapyDisease /Disorder Prevention /ControlHuman Therapy EvaluationInsulinInsulin Dependent Diabetes MellitusPancreatic IsletsHyperinsulinismDevelopmental NeurobiologyDiabetes MellitusHypoglycemiaNewborn Human (0-6 Weeks)Child (0-11)Relapse /Recurrence
Grant awards (8)
DIABETES PREVENTION TRIAL--TYPE I DIABETES SCREENING/STAGING$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES SCREENING/STAGING$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES SCREENING/STAGING$25,799
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES SCREENING/STAGING$0
M01 · FY2000 · RR
HYPOGLYCEMIA IN CHILDREN W/ DIABETES OR NEONATAL HYPERIN$0
M01 · FY2000 · RR
HYPOGLYCEMIA IN CHILDREN W/ DIABETES OR NEONATAL HYPERIN$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES SCREENING/STAGING$0
M01 · FY2000 · RR
HYPOGLYCEMIA IN CHILDREN W/ DIABETES OR NEONATAL HYPERIN$0
M01 · FY2000 · RR